Top of this page
Skip navigation, go straight to the content

Our Products Products Briviact® - Epilepsy


image description


In Europe, Briviact® (brivaracetam) is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.



In the US, BRIVIACT® (brivaracetam) CV is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.


Other countries

For availability of Briviact® in other countries, please consult our local websites.